Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry
Seek Labs has been awarded U.S. Patent No. 12,618,795 B2 for its Asymmetric Semi-Nested Isothermal Nucleotide Amplification (ANINA) technology, which is an essential part of its Seek Amplification™ system designed for molecular diagnostics. This innovative patent positions Seek Labs to enhance decentralized testing capabilities in the field of molecular diagnostics.
SALT LAKE CITY–(BUSINESS WIRE)– #SeekLabs–Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, today announced the United States Patent and Trademark Office has issued U.S. Patent No. 12,618,795 B2, covering Asymmetric Semi-Nested Isothermal Nucleotide Amplification (ANINA), a key assay design component of the company’s nucleic acid amplification chemistry for use in molecular diagnostic systems, called Seek Amplification™. Molecular diagnostics